Home » Stocks » JANX » Financials

Janux Therapeutics, Inc. (JANX)

Stock Price: $27.60 USD -0.81 (-2.85%)
Updated Jul 27, 2021 4:00 PM EDT - Market closed

Income Statement (Annual)

Numbers in millions USD. Fiscal year is January - December.
Year20202019
Revenue--
Selling, General & Admin1.800.77
Research & Development3.043.00
Operating Expenses4.843.77
Operating Income-4.84-3.77
Interest Expense / Income0.210.23
Other Expense / Income1.740.00
Pretax Income-6.78-4.00
Net Income-6.78-4.00
Shares Outstanding (Basic)0.920.67
Shares Outstanding (Diluted)0.920.67
Shares Change36.71%-
EPS (Basic)-7.41-5.98
EPS (Diluted)-7.41-5.98
Free Cash Flow Per Share-4.77-5.72
EBITDA-6.57-3.77
EBIT-6.58-3.77